ERBA Diagnostics settlements

ERBA Diagnostics, Inc. is the subject of a securities class action settlement covering investors who purchased ERBA Diagnostics securities on the NYSE between June 14, 2013 and November 20, 2015. The $1,215,000 total settlement provided an average gross recovery of approximately $0.17 per share, or roughly $0.11 per damaged share after fees and expenses. The claim deadline of December 10, 2018 has long since passed — SettleSignal maintains this record for investors researching ERBA's litigation history.

Check what you may be owed Free · takes 20 seconds

Published directory

1 published record

Proof required

False Advertising

Erba

ERBA Diagnostics settled a securities fraud lawsuit covering investors who bought its stock on the NYSE between June 14, 2013 and November 20, 2015. The $1,215,000 settlement paid an average gross recovery of about $0.17 per share, roughly $0.11 after fees and expenses. The claim-filing window closed in 2018.

Claim window closed Evidence-verified

Related companies with published settlements

Share this collection — free to repost with a link back.

There may be money with your name on it.

Free to browse and track. Every record shows its official-evidence status — and you open the official claim form yourself.

Check what you may be owed Browse all settlements